Ensign Peak Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $792K | Hold |
|
|||||
|
2025
Q1 | $663K | Hold |
|
|||||
|
2024
Q4 | $665K | Hold |
|
|||||
|
2024
Q3 | $672K | Hold |
|
|||||
|
2024
Q2 | $546K | Hold |
|
|||||
|
2024
Q1 | $449K | Sell |
|
|||||
|
2023
Q4 | $556K | Hold |
|
|||||
|
2023
Q3 | $657K | Hold |
|
|||||
|
2023
Q2 | $654K | Hold |
|
|||||
|
2023
Q1 | $774K | Buy |
|
|||||
|
2022
Q4 | $936K | Buy |
|
|||||
|
2022
Q3 | $672K | Buy |
|
|||||
|
2022
Q2 | $548K | Hold |
|
|||||
|
2022
Q1 | $843K | Hold |
|
|||||
|
2021
Q4 | $718K | Buy |
|